oNKo-innate
Matthew Veldman has worked as a Scientist at oNKo-Innate Pty Ltd since September 2019. Prior to that, they worked as a Research Assistant at Monash University from November 2017 to September 2019.
Matthew Veldman completed their Bachelor of Science (Honours) degree in Biochemistry and Molecular Biology from Monash University between the years 2013 and 2017.
oNKo-innate
oNKo-innate is a discovery-stage biotechnology company dedicated to target identification and pre-clinical immuno-oncology drug development. With our deep understanding of Natural Killer (NK) cells, we aim to be the first to truly therapeutically harness the cancer-fighting abilities of these remarkable white blood cells.